Größe auswählen
€ 838,00
€ 2.760,00
€ 16.960,00
€ 838,00
Über diesen Artikel
Fortfahren mit
Biologische Quelle
Serratia marcescens
Qualitätsniveau
Rekombinant
expressed in E. coli
Sterilität
non-sterile
Produktlinie
EMPROVE® EXPERT
Assay
≥99% (SDS-PAGE)
Form
buffered aqueous glycerol solution
Leistungsmerkmale
autoclavable: no
Konzentration
≥250 units/μL
Verunreinigungen
≤0.25 EU/kU bacterial endotoxins
Anwendung(en)
pharma/biopharma processes
Versandbedingung
dry ice
Lagertemp.
-10 to -25°C
1 of 4
Dieser Artikel | 70746 | 70664 | E8263 |
|---|---|---|---|
| assay ≥99% (SDS-PAGE) | assay >90% (SDS-PAGE) | assay >99% (SDS-PAGE) | assay ≥99% (SDS-PAGE) |
| shipped in dry ice | shipped in wet ice | shipped in wet ice | shipped in wet ice |
| biological source Serratia marcescens | biological source Serratia marcescens | biological source Serratia marcescens | biological source Serratia marcescens |
| form buffered aqueous glycerol solution | form buffered aqueous glycerol solution | form buffered aqueous glycerol solution | form buffered aqueous glycerol solution |
| concentration ≥250 units/μL | concentration 25-29 units/μL | concentration 25-29 units/μL | concentration ≥250 units/μL |
| application(s) pharma/biopharma processes | application(s) research use | application(s) research use | application(s) research use |
Allgemeine Beschreibung
The enzyme consists of two subunits of 30 kDa each. It is functional between pH 6 and 10 and from 0-42°C and requires 1-2 mM Mg2+ for activation. The enzyme is also active in the presence of ionic and non-ionic detergents, reducing agents, PMSF (1 mM), EDTA (1 mM) and urea (relative activity depends on specific conditions). Activity is inhibited by <150 mM monovalent cations, <100 mM phosphate, <100 mM ammonium sulfate, or <100 mM guanidine HCl.
M-Clarity Program
As part of our EMPROVE® Program, our raw materials are offered with EMPROVE® Dossiers which provide comprehensive, up-to-date documentation to help you navigate regulatory challenges, manage risks, and improve your manufacturing processes.
Our comprehensive portfolio of downstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Ranging from non-GMP grades for low-risk application, to IPEC-PQG GMP for higher-risk applications, we have products covering all your manufacturing needs.
Anwendung
Verpackung
- 100,000 Units
- 500,000 Units
- 5,000,000 Units + 50,000 Units tailgate sample
Angaben zur Herstellung
Rechtliche Hinweise
Ähnliches Produkt
Lagerklassenschlüssel
10 - Combustible liquids
WGK
WGK 1
Bleiben Sie mit dem Emprove®-Programm GMP-konform
Beschleunigen Sie die Qualifizierung, halten Sie die Vorschriften ein und sparen Sie Zeit mit Emprove® Dossiers.
Hinweis: Sie werden zu EmproveSuite.com weitergeleitet. Ihr Benutzername und Passwort sind von SigmaAldrich.com getrennt und können abweichen.
Registrieren Sie sich kostenlos und erhalten Sie innerhalb weniger Minuten Zugang zu Emprove® Dossiers. Aktualisieren Sie Ihr Abonnement, um erweiterte und angepasste Inhalte in der Emprove® Suite freizuschalten.
Sie finden nicht, was Sie suchen? Besuchen Sie die Emprove® Programm-Hilfeseite.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Artikel
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
This page describes key considerations for cell lysis and how the combination of a high salt concentration and a salt tolerant endonuclease can be used to increase vector titer and infectivity during AAV vector manufacturing.
Benzonase®endonuclease efficiently removes nucleic acid contaminants from viral production, crucial for cell and gene therapies and vaccines.
Verwandter Inhalt
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Active Filters
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung
